PS2 protein expression in gastric carcinoma. an immunohistochemical and immunoradiometric study

European Journal of Cancer Part A

Volumn 32, Issue 9, 1996, Pages 1574-1579

  Machado, J C ^a   Carneiro, F ^b   Ribeiro, P ^c   Blin, N ^a   Sobrinho Simoes, M ^b  

^a University of Porto   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Gastric carcinoma; Immunohistochemistry; Immunoradiometric assay (irma); Mucins; Ps2; Stomach; Survival; Trefoil peptides

Indexed keywords

EID: 33748457171     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982, 10, 7895-7903.
2. Rio MC, Bellocq JP, Gairard B, et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. ProcNatlAcad Sci USA 1987, 84, 9243-9247.
3. Skilton RA, Luqmani YA, McClelland RA, Coombes RC. Characterisation of a messenger RNA selectively expressed in human breast cancer. BrJ Cancer 1989, 60, 168-175.
4. Pallud C, Le Doussal V, Pichon MF, Prud'homme JF, Hacene K, Milgrom E. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours. Histopathology 1993, 23, 249-256.
5. Henry JA, Nicholson S, Hennessy C, Lennard TW, May FE, Westley BR. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. BrJ Cancer 1990, 61, 31-38.
6. Foekens JA, Rio MC, Seguin P, et al. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res 1990, 50,3832-3837.
7. Cappelletti V, Coradini D, Scanziani E, Benini E, Silvestrini R, Di Fronzo G. Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in nodenegative breast cancer. Eur J Cancer 1992, 28A, 1315-1318.
8. Hähnel E, Robbins P, Hähnel R. Expression of the pS2 gene in normal breast tissue. Breast Cancer Res Treat 1993, 28, 295-297.
9. Rio MC, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 19S8, 241, 705-708.
10. Luqmani Y, Bennett C, Paterson I, et al. Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 1989, 44, 806-812.
11. Wright NA, Poulsom R, Stamp GW, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990, 162, 279-284.
12. Piggott NH, Henry JA, May FE, Westley BR. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 1991,163, 95-104.
13. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Spasmolytic polypeptide is a major antrat peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993, 105, 1110-1116.
14. Müller W, Borchard F. pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival. J Pathol 1993, 171, 263-269.
15. Henry JA, Bennett MK, Piggott NH, Levett DL, May FE, Westley BR. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. BrJ Cancer 1991, 64, 677-682.
16. Theisinger B, Welter C, Seitz G, et al. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic poly-peptide gene (hSP) in diffuse type of stomach carcinoma. EurJ Cancer 1991, 27A, 770-773.
17. Higashiyama M, Doi O, Kodama K, et al. Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. EurJ Cancer 1994, 30A, 792-797.
18. David L, Sansonetty F, Soares P, et al. DNA content of gastric lesions with particular emphasis on gastric carcinoma. A study of 71 consecutive cases using flow cytometry. Surg Pathol 1994, S, 211-224.
19. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981, 75, 734-738.
20. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein dye binding. AnalBiochem 1976, 72, 248-254.
21. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64, 31-49.
22. Fiocca R, Villani L, Tenti P, et al. Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of 'early' and 'advanced' tumors. Pathol Res Pra1987,182, 308-325.
23. Carneiro F, Moutinho-Ribeiro M, David L, et al. Signet ring cell carcinoma of the stomach: a morphometric, ultrastructural and DNA cytometric study. Ultrastruct Pathol 1992, 16, 603-614.
24. Fiocca R, Cornaggia M, Villani L, Capella C, Solcia E, Samloff IM. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node métastases. Cancer 1988, 61, 956-962.
25. Kushima R, Hattori T. Histogenesis and characteristics of gastrictype adenocarcinomas in the stomach. J Cancer Res Clin Oncol 1993,120, 103-111.
26. Carneiro F, Seixas M, Sobrinho-Simôes M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 1995, 191, 571-584.
27. Willemse F, Nap M, Eggink HF, Foekens JA, Henzenlogmans SC, Vanputten WLJ. Quantification of relative area of pS2 immunohistochemical staining and epithelial percentage in breast carcinomas: the effect of the latter on the interpretation of a cytosolic pS2 assay. Mod Pathol 1995, 8, 521-525.
28. Machado JC, Carneiro F, Gärtner F, Ribeiro P, Sobrinho-Simôes M. Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study. EurJ Cancer Prev 1994, 3, (Suppl. 2), 31-37.
29. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993, 104, 12-20.